 
        Mrs  
        Jossie  
        Cahyani  
        
        Mrs  
        Jossie  
        Cahyani  
        Veterinary Medicine in Animal Vaccines and Kit Production  
        Central for Veterinary Biologics, Directorat General Livestock and Animal Health Service, Ministry of Agriculture, Indonesia  
Biography
        Jossie Intan Cahyani, DVM
Veterinary Medicine in Central for Veterinary Biologics, Directorate General Livestock and Animal Health Service, Ministry of Agriculture, Indonesia from 2008 - Now
Responsibility :
2008 - 2010 : Animal Health
2010 - 2013: Anthrax and Brucella Vaccine Production
2013 - 2014: Rabies Vaccine Production
2014 - 2022: Avian Vaccine Production
2017 - 2020: Postgraduate/Master student (Veterinary Science) in Gajah Mada University, Indonesia
2020 - 2021: Toxoplasma Rapid Kit Production
2022 - Now: Quality Control in Central for Veterinary Biologics
Research interests
        Vaccinology, Immunology, Microbiology, Celluler Biology
Projects you're working on
        Rapid Kit for Toxoplasma
Discipline
        Bacteriology      Bio-manufacturing      Cellular biology      Challenge model development      Clinical trials – efficacy      Clinical trials – safety      Commercialisation      Deployment      Epidemiology      Formulation technology      Immunology – B-cells      Immunology – T-cells      Immunology – innate      Molecular biology      Parasitology      QC test development      Quality assurance      Safety evaluation      Virology  Host species
        Cattle      Pigs      Poultry      Small ruminants      Zoonoses  Pathogen
        Bacteria      Bacteria›Brucella      Bacteria›Salmonella      Parasites      Viruses      Viruses›African swine fever virus      Viruses›Foot-and-mouth disease virus      Viruses›Influenza virus      Viruses›Newcastle disease virus      Viruses›Paramyxoviruses      Viruses›Rabies virus  Stage of vaccine development
        Adjuvants      Antigen discovery and immunogen design      Clinical trials      Commercialisation      Correlates of protection – immunomonitoring      Deployment      Field trials      Pre-clinical trials      Vaccine delivery